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Abstract
Background: A key feature of the inflammatory response after cerebral ischemia is the brain infiltration of blood
monocytes. There are two main monocyte subsets in the mouse blood: CCR2+Ly6Chi “inflammatory” monocytes
involved in acute inflammation, and CX3CR1+Ly6Clo “patrolling” monocytes, which may play a role in repair
processes. We hypothesized that CCR2+Ly6Chi inflammatory monocytes are recruited in the early phase after
ischemia and transdifferentiate into CX3CR1+Ly6Clo “repair” macrophages in the brain.
Methods: CX3CR1GFP/+CCR2RFP/+ bone marrow (BM) chimeric mice underwent transient middle cerebral artery
occlusion (MCAo). Mice were sacrificed from 1 to 28 days later to phenotype and map subsets of infiltrating
monocytes/macrophages (Mo/MΦ) in the brain over time. Flow cytometry analysis 3 and 14 days after MCAo in
CCR2−/− mice, which exhibit deficient monocyte recruitment after inflammation, and NR4A1−/− BM chimeric mice,
which lack circulating CX3CR1+Ly6Clo monocytes, was also performed.
Results: Brain mapping of CX3CR1GFP/+ and CCR2RFP/+ cells 3 days after MCAo showed absence of CX3CR1GFP/+ Mo/MΦ
but accumulation of CCR2RFP/+ Mo/MΦ throughout the ischemic territory. On the other hand, CX3CR1+ cells accumulated
14 days after MCAo at the border of the infarct core where CCR2RFP/+ accrued. Whereas the amoeboid morphology of
CCR2RFP/+ Mo/MΦ remained unchanged over time, CX3CR1GFP/+ cells exhibited three distinct phenotypes: amoeboid cells
with retracted processes, ramified cells, and perivascular elongated cells. CX3CR1GFP/+ cells were positive for the Mo/MΦ
marker Iba1 and phenotypically distinct from endothelial cells, smooth muscle cells, pericytes, neurons, astrocytes,
or oligodendrocytes. Because accumulation of CX3CR1+Ly6Clo Mo/MΦ was absent in the brains of CCR2 deficient
mice, which exhibit deficiency in CCR2+Ly6Chi Mo/MΦ recruitment, but not in NR4A1−/− chimeric mice, which
lack of circulating CX3CR1+Ly6Clo monocytes, our data suggest a local transition of CCR2+Ly6Chi Mo/MΦ into
CX3CR1+Ly6Clo Mo/MΦ phenotype.
Conclusions: CX3CR1+Ly6Clo arise in the brain parenchyma from CCR2+Ly6Chi Mo/MΦ rather than being de
novo recruited from the blood. These findings provide new insights into the trafficking and phenotypic diversity
of monocyte subtypes in the post-ischemic brain.
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Background
Activation of brain-resident cells and mobilization of cir-
culating leukocytes is a key feature of the inflammatory
response after cerebral ischemia [1]. In animal models as
in human stroke, post-ischemic brain inflammation is
characterized by infiltration of hematogenous immune
cells, monocyte-derived tissue macrophages (Mo/MΦ)
being one of the predominant cell types [2–5]. Growing
evidence suggests that Mo/MΦ invading the ischemic
brain can contribute to both brain injury [6, 7] and re-
pair [8, 9]. These opposing roles reflect the heterogeneity
of the monocyte-macrophage lineage, which may adopt
diverse phenotypes depending on environmental cues [10].
Two predominant subsets of circulating monocytes
(CD115+ leukocytes) are found in the blood of rodents
and humans: “inflammatory ” and “patrolling” mono-
cytes. In mice, inflammatory monocytes are character-
ized by the expression of the C-C chemokine receptor
type 2 (CCR2), a critical molecule involved in the rapid
recruitment of the cells into inflamed tissues [11]. They
also express high levels of lymphocyte antigen 6 complex
locus C1 (Ly6C) but low to intermediate levels of C-
X(3)-C motif chemokine receptor 1 (CX3CR1). On the
other hand, CX3CR1, the high-affinity functional che-
mokine receptor for fractalkine (CX3CL1), is enriched in
patrolling monocytes, which do not express Ly6C and
CCR2 or express them at low levels. Patrolling mono-
cytes (Ly6CloCCR2−CX3CR1+) have longer half-life and
crawl on the vessel luminal wall orchestrating the disposal
of damaged endothelial cells [12]. In addition, patrolling
monocytes can rapidly invade tissues in response to tissue
damage or infection [13, 14]. Patrolling monocytes were
previously thought to originate from circulating inflamma-
tory CD115+Ly6Chi monocytes [14, 15], but recent data
suggest that they originate from distinct myeloid progeni-
tors by the activity of the nuclear receptor subfamily 4,
group A, member 1 transcription factor NR4A1 (Nur77)
in the BM [16]. Furthermore, depletion of CD115+Ly6Chi
monocytes in the circulation does not affect the numbers
of CD115+Ly6Clo monocytes, reducing the likelihood
that the sole precursors of “patrolling” monocytes are
CD115+Ly6Chi cells [17].
Little is known about the monocytes subtypes invading
the ischemic brain, their morphology, and their fate once
in the tissue. Monocytes infiltrating the ischemic brain
acquire morphological and functional properties of tissue
macrophages and can persist in the brain parenchyma for
extended periods of time [7, 8, 18–20]. However, the traf-
ficking of inflammatory and patrolling monocytes into the
ischemic brain, their relationship to the development of
tissue injury, and their long-term fate remain unknown.
Here, we investigated the temporal profile, spatial distri-
bution, and phenotype of inflammatory (CCR2+Ly6Chi) and
patrolling (CX3CR1+Ly6Clo) monocyte subpopulations in
transient focal cerebral ischemia. Using a mouse model to
track CCR2 and CX3CR1 expression in hematogenous
cells, we found that CCR2+ Mo/MΦ invade the brain in the
acute phase and give rise to CX3CR1+ Mo/MΦ during the
subacute and chronic phase of the injury, without the par-
ticipation of circulating CX3CR1+ Mo. The findings identify
CCR2+Ly6Chi monocytes as the primary monocytic cell in-
filtrating the ischemic brain, where they undergo pheno-
typic transformation during the evolution of the damage.
Such phenotypic diversity may underlie the multiplicity of
roles attributed to Mo/MΦ in ischemic brain injury.
Methods
Mice
Experiments were performed in 8–12-week-old male
CCR2RFP/+CX3CR1GFP/+, CCR2−/−, or NR4A1−/− on a
C57Bl/6J genetic background. Age-matched wild-type
(WT) mice (C57Bl/6J, Jackson Laboratory, Bar Harbor,
ME) served as controls. All animal experiments were per-
formed in accordance with the ARRIVE guidelines [21].
Middle cerebral artery occlusion
Transient focal cerebral ischemia was induced using the
intraluminal filament model of middle cerebral artery
occlusion (MCAo), as described previously [22]. Under
isoflurane anesthesia (maintenance 1.5-2 %), a heat-
blunted nylon suture (6/0) was inserted into the right
external carotid artery of anesthetized mice and ad-
vanced until it obstructed the middle cerebral artery
(MCA). This was confirmed by cerebral blood flow
(CBF) measured using transcranial laser Doppler flow-
metry (Periflux System 5010, Perimed, King Park, NY)
in the territory of the right MCA (2 mm posterior,
5 mm lateral to bregma). The filament was left in place
for 35 min and then withdrawn. Only animals that ex-
hibited a reduction in CBF of >85 % during MCA occlu-
sion and in which CBF recovered by >80 % after 10 min
of reperfusion were included in the study. Inadequate
ischemia-reperfusion was found to be <4 % in the study
and not different among groups. Rectal temperature was
monitored and kept constant (37.0 ± 0.5 °C) during the
surgical procedure and in the recovery period until the
animals regained full consciousness. No differences were
found in mortality rate (<1 %) among groups.
Bone marrow CCR2RFP/+CX3CR1GFP/+ and NR4A1−/− chimera
generation
CCR2RFP/RFP (JAX 017586) and CX3CR1GFP/GFP (JAX
005582) mice were crossed to obtain heterozygous mice
that underwent chromosome recombination between
the CCR2 and CX3CR1 loci (CCR2RFP/+CX3CR1GFP/+
mice). Recombination of CCR2 and CX3CR1 loci was
confirmed by polymerase chain reaction (PCR) using tail
DNA. DNA was purified from tails using NaOH extraction
Garcia-Bonilla et al. Journal of Neuroinflammation  (2016) 13:285 Page 2 of 13
[23]. Target primer sequences were CX3CR1_for 5′-TCTG
CTGAGGCCTGTTATTTG-3′ and CX3CR1_rev 5′-ACC
AGACCGAACGTGAAGAC-3′; enhanced green fluores-
cent protein (EGFP)_for 5′-ctgaccctgaagttcatctgc-3′ and
EGFP_rev 5′-gcttgtcggccatgatataga-3′; CCR2_for 5′-GGAT
TAAGGAATTTGGCATTTG-3′, CCR2_rev 5′-GGAGTA
GAGTGGAGGCAGGA-3′, and red fluorescent protein
(RFP)_rev 5′-CTTGATGACGTCCTCGGAG-3′. All
primers were purchased from Invitrogen Life Tech-
nologies (Grand Island, NY). qRT-PCR was conducted
with 3 μl of diluted DNA (1:10 dilution), in duplicate
15 μl reactions using the Maxima SYBR Green/ROX
qPCR Master Mix (2×) (Thermo Scientific, Pittsburgh,
PA). The reactions were incubated at 50 °C for 2 min
and then at 95 °C for 10 min. A polymerase chain re-
action cycling protocol consisting of 15 s at 95 °C and
1 min at 60 °C for 45 cycles was employed. Genotyp-
ing results were based on melting curve analysis.
Whole-body irradiation was performed in 7-week-old
male WT mice with a lethal dose of 9.5 Gy of γ radiation
using a 137Cs source (Nordion Gammacell® 40 Exactor,
Theratronics, Ottawa, Canada). Eighteen hours later, irra-
diated mice were transplanted with BM cells (2 × 106, i.v.)
isolated from 7-week-old donor CCR2RFP/+CX3CR1GFP/+
mice. Donor BM cells were flushed out with 2–3 ml of
phosphate-buffered saline (PBS) from the femur and tib-
ias, filtered through a 40-μm nylon mesh and counted for
viability before injection. Transplanted mice were housed
in cages with sulfatrim pellets for the first 2 weeks after ir-
radiation. The restricted expression of green fluorescent
protein (GFP) in hematogenous CX3CR1 cells allows for
differentiation of infiltrating CX3CR1GFP/+ monocytes
from central nervous system (CNS)-resident CX3CR1+
microglia. In a distinct group of WT mice, irradiation with
head protection was performed using a custom designed
lead shield (2.5 cm thickness) under the aforementioned
irradiation procedure. For NR4A1−/− chimera generation,
WT mice were lethally irradiated as described above, and
donor BM from NR4A1−/− mice (JAX 006187) was used
to produce WT mice with NR4A1-null leukocytes. Dele-
tion of NR4A1 in blood leukocytes was analyzed in the
chimeric mice by determining the absence of Ly6Clo
monocytes in blood by flow cytometry.
Image analysis and cell counting of infiltrating
CX3CR1GFP/+ and CCR2RFP/+ cells
Mice were perfused transcardially with ice-cold PBS
followed by 4 % paraformaldehyde in PBS. Brains were
removed, stored overnight in the same fixative at 4 °C,
and then submerged in 30 % sucrose solution for 2 days
and frozen. Using a cryostat, 12 serial coronal sections
(thickness 16 μm) were cut every 600 μm from the
frontal cortex to the caudal hippocampus (+3.14 to −3.46
bregma) and then mounted on slides (Fig. 1b). Fluorescent
images were acquired by a scientific monochrome CCD
camera (Retiga EXi, QImaging) using fluorescein isothio-
cyanate (FITC) (CX3CR1-GFP) and Texas Red (CCR2-
RFP) filter sets through a 10× objective on a Nikon
TE2000 microscope equipped with a motorized stage. Ac-
quisition was controlled via software (IPLab, Biovision
Technologies, Exton, PA) using a custom script. Individual
image files (80 for each hemisphere) were combined using
the ImageJ software (National Institute of Health, version
1.45) by invoking a stitching algorithm [24]. A custom
ImageJ macro was used to semi-automatically count cells
identified after thresholding the image based on pixel
values. In lesions at 14 and 28 days after ischemia,
we observed a densely populated lesion core where
individual cells could not be unequivocally separated
from neighboring cells. Therefore, these areas were
excluded from the analysis. For presentation pur-
poses, binary image masks of both green and red
channel images generated for cell counting were
superimposed on a grayscale image obtained from
the FITC channel image by running the ImageJ
“Remove Outliers” command once and the ImageJ
“Smooth” command twice.
Immunofluorescence
Frozen brain sections were permeabilized with 0.5 %
Triton X-100 (Sigma) in PBS (PBST) for 30 min at room
temperature, blocked with 5 % normal donkey serum
(NDS) in 0.1 % in PBST and incubated with antibodies
against the neuronal marker NeuN (1: 100, mouse
monoclonal; Millipore), the endothelial cell marker glucose
transporter 1 (GLUT-1) (1:200, rabbit polyclonal antibody;
Calbiochem), the astrocytic marker glial fibrillary acidic
protein (GFAP) (1:200, mouse monoclocal; Sigma-Aldrich),
the microglia/macrophage marker ionized calcium binding
adaptor molecule 1 (Iba1) (1:500, rabbit polyclonal anti-
body; Wako Chemicals), the pericyte marker beta-type
platelet-derived growth factor receptor (PDGFRβ) (1:200,
rat polyclonal antibody; Abcam), the vascular smooth
muscle cells marker α-actin (1:800, rabbit polyclonal anti-
body; Abcam), or the oligodendrocyte marker Olig2 (1:200,
rabbit polyclonal antibody; Abcam) in 1% NDS-0.1 % PBST
at 4 °C overnight. Ki67 was used as a cell proliferation
marker (1: 200, rabbit polyclonal; Millipore). After three 10-
min washes with 0.1 % PBST, brain slices were incubated
with a FITC-, DyLight 405-, or a Cy5-conjugated secondary
antibody (1:200; Jackson ImmunoResearch Laboratories).
For antigen retrieval, boiling 10 mM sodium citrate buffer
was applied on brain sections for 5 min before initiating
immunostaining for NeuN or Ki67. Brain sections were
then mounted on slides and immunostaining was visualized
by confocal microscopy (Leica TCS SP5, Mannheim,
Germany) or with an epifluorescence microscope (IX83
Inverted Microscope, Olympus, Center Valley, PA). The
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specificity of the immunofluorescence was verified in
pilot studies by omission of the primary antibody.
The proportion of morphological phenotypes of
CX3CR1GFP/+ cells was quantified within the ischemic
hemisphere in images acquired with a 40× objective from
1.3, 0.7, −0.1, −0.5, and −1.1 bregma coronal brain sec-
tions at 14 days post-MCAO that were stained for
GLUT-1 using ImageJ software. For the analysis of Ki67
+ cells, coronal sections were scanned with a confocal
microscope and Ki67+ and CX3CR1GFP/+ cells were
quantified from tile-scanned images using ImageJ
software.
Brain mononuclear cell isolation
Mice were transcardially perfused under deep anesthesia
with 30 ml of heparinized saline to remove blood cells.
The ischemic hemisphere was separated from the cerebel-
lum and olfactory bulb and homogenized with a dounce
homogenizer in RPMI Medium 1640 with Phenol Red.
Then, the cell suspension was subjected to discontinuous
70 %/25 % Percoll (GE Healthcare, Piscataway, NJ) density
gradient centrifugation (30 min, 500 g, 4 °C). Enriched-
mononuclear cells were collected from the interphase,
washed with Hepes-HBSS buffer (138 mM NaCl, 5 mM
KCl, 0.4 mM Na2HPO4, 0.4 mM KH2PO4, 5 mM D-Glu-
cose, 10 mM Hepes, pH 7.4), and resuspended in 2 % fetal
bovine serum (FBS) in PBS FACS buffer for staining and
FACS analysis.
Flow cytometry and cell sorting
Rat monoclonal antibodies used for flow cytometry analysis
include CD45-BV 510 or CD45-APC (clone 30 F-11),
Ly6C-FITC (clone HK1.4), CX3CR1-PE (clone SA011F11),
Ly6G-PerCP-Cy5.5 (clone 1A8), CD8a-PerCP-Cy5.5 (clone
53–6.7), CD115-PE (clone AFS98), NK1.1-APC (clone
PK136), and CD11b-APC-Cy7 (clone M1/70) from
Fig. 1 Spatio-temporal profile of CX3CR1GFP/+ and CCR2RFP/+ Mo/MΦ infiltration after stroke. a Anatomical localization of CCR2-RFP (red) and
CX3CR1-GFP (green) cells infiltrating the ischemic hemisphere in coronal brain sections of CCR2RFP/+CX3CR1GFP/+chimeric mice 3, 14, or 28 days
after MCAo and in sham mice. Infarct volume was outlined in serial cresyl violet stained sections 3 days after MCAo and overlaid on fluorescent
images (dotted line). b Quantification of infiltrating CX3CR1GFP/+ and CCR2RFP/+ cells in sham mice and stroke mice 1, 2, 3, 5, 7, 14, and 28 days
after MCAo (n = 3–4 mice/group). *p < 0.05 and ***p < 0.001 vs. Sham. c Quantification of infiltrating CX3CR1GFP/+CCR2RFP/+ double-positive cells
in sham mice and stroke mice 1, 2, 3, 5, 7, 14, and 28 days after MCAo (n= 3–4 mice/group). **p< 0.01 vs. Sham. d Diagram depicting the brain-sectioning
method. The brain was sectioned in 12 coronal slices at 600-μm intervals, beginning from the frontal pole and proceeding in caudal direction
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BioLegend (San Diego, California) and CCR2-APC (clone
475301) from R&D. For flow cytometric analysis of blood
leukocytes, 100 μl of blood was withdrawn by cardiac punc-
ture from mice under deep anesthesia immediately before
sacrifice. Erythrocytes were lysed by incubating the blood
three times with 5 ml erythrocyte lysis buffer (0.15 M
NH4Cl, 1 mM KH2CO3, and 0.1 mM Na-EDTA) for 5 min
at room temperature. Blood leukocytes were resuspended
in FACS buffer. Cells were blocked with CD16/CD32
antibody for 10 min at 4 °C, stained with predeter-
mined optimal concentrations of antibodies for 20 min
at 4 °C, and analyzed on a MACSQuant (Miltenyi Bio-
tec) or a FACSCalibur (Becton-Dickinson) cytometer.
Dead cells and debris were excluded based on side and
forward scatter profiles (SSC and FSC, respectively).
Appropriate isotype control antibodies, “fluorescence
minus one” staining and staining of negative popula-
tions were used to establish compensation parameters
and sorting gates. Absolute cell numbers and frequencies
were recorded. Data were analyzed using FlowJo software
(FlowJo, Ashland, OR).
Data analysis
Data are expressed as mean ± SE. Intergroup differences
were analyzed using a Student unpaired t test or one-way
ANOVA, as appropriate. Differences were considered sta-
tistically significant for p < 0.05. Animals were randomly
assigned to treatment and control groups and analysis was
performed in a blinded fashion.
Results
CCR2+ Mo/MΦ accumulate in the ischemic brain before
CX3CR1+ Mo/MΦ
To investigate brain trafficking of monocytes after cere-
bral ischemia, we generated CX3CR1GFP/+CCR2RFP/+
BM chimeric mice. GFP and RFP expression enables to
simultaneously track CX3CR1+Ly6Clo and CCR2+Ly6Chi
monocyte recruitment, while the generation of BM
chimeras, allows for differentiation between infiltrating
CX3CR1GFP/+ monocytes and CNS-resident (CX3CR1+)
microglia [25]. Histological analysis of brains of
CX3CR1GFP/+CCR2RFP/+ chimeras that underwent MCAo
revealed a significant infiltration of monocytes in the is-
chemic brain (Fig. 1). CCR2RFP/+ cells rapidly increased in
the ischemic hemisphere 3 days after MCAo, evenly in-
filtrating the injured tissue, identified by Nissl stain of
adjacent brain sections, with minimal penetration of
the healthy tissue (Fig. 1a). During the subacute and
chronic phase of injury (day 14–28 after MCAo),
CCR2RFP/+ cells were confined to the lesion core and
their number decreased elsewhere (Fig. 1a). The number
of CCR2RFP/+ cells was highly dense in the lesion core 14–
28 days after ischemia, which made it impossible to differ-
entiate single cells, and therefore, this region was excluded
for the quantitative analysis (see the “Methods” section;
Fig. 1b). CX3CR1GFP/+ cell numbers increased moderately
in the first 7 days after MCAo and peaked at 14–28 days
post-ischemia (Fig. 1a-b). CX3CR1GFP/+ cells delimited the
CCR2RFP/+ cell-laden core at 14 days after MCAo and
were also found, albeit sparsely, throughout the entire le-
sion. This anatomical distribution remained unmodified
28 days after MCAo (Fig. 1a). In brains of mice undergo-
ing sham surgery, CCR2RFP/+ and CX3CR1GFP/+ cells were
scarce and localized mostly in the choroid plexus, olfac-
tory bulbs and meninges (Fig. 1a). Moreover, the number
of CCR2RFP/+CX3CR1GFP/+ double-positive cells was
homogenous among the sham and 1–2 days post-ischemia
groups (20 ± 3 % CCR2RFP/+CX3CR1GFP/+ of total
CX3CR1GFP/+) and increased 3–5 days after MCAo
(33 ± 3 %) before significantly decreasing between 7
and 28 days after MCAo (6 ± 2 %, Fig. 1c).
Because irradiation of the head may induce an inflamma-
tory response [26] that may alter immune cell infiltration,
CX3CR1GFP/+CCR2RFP/+ chimeric mice were also obtained
by irradiation with head shielding (Additional file 1: Figure
S1). However, head shielding had no effect on brain distri-
bution of CCR2RFP/+ and CX3CR1GFP/+ cells 3 and 14 days
after stroke, when compared to chimeric mice without head
protection (Additional file 1: Figure S1A–B).
Infiltrating CX3CR1+ cells but not CCR2+ cells displayed
different morphological phenotypes
CX3CR1GFP/+ cells exhibited three distinct phenotypes
14 and 28 days after MCAo (Fig. 2a): (i) cells with an
amoeboid morphology and no plasmalemmal processes,
classified as amoeboid cells (left panel); (ii) cells with ar-
borized processes, named ramified cells (central panel);
and (iii) cells with elongated shape located along the ves-
sels termed perivascular cells (right panel). Amoeboid
CX3CR1GFP/+ cells were often localized in the ischemic
core and adjacent areas (95 ± 1.2 % of the total
CX3CR1GFP/+ cells), which were mainly populated by
CCR2+ cells. Ramified CX3CR1GFP/+ cells were predomin-
ant at the periphery of the lesion (85 ± 1.9 % of the total
CX3CR1GFP/+ cells) and were not seen in the core at
14 days after MCAo. Perivascular CX3CR1GFP/+ cells were
closely associated with blood vessels identified by the
endothelial marker GLUT1 and were observed in both
core (5 ± 1.0 %) and peri-infarct (5.8 ± 1.0 % of the total
CX3CR1GFP/+ cells) regions (Fig. 2a). These perivascular
cells exhibited elongated profiles along the major axis of
the vessel or encircled the entire vessels’ circumference in
vascular cross sections. Similar distributions were ob-
served 28 days after MCAo (data not shown). Head
shielding did not affect the phenotype distribution of
CX3CR1GFP/+ cells (Additional file 1: Figure 1D). In
contrast, infiltrating CCR2RFP/+ cells showed a uniform
round shape without apparent processes, distinctive of
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Fig. 3 CX3CR1GFP/+ Mo/MΦ proliferate in the ischemic brain. a Co-staining of CX3CR1GFP/+ with the proliferation marker Ki67 shows that some
CX3CR1GFP/+ Mo/MΦ (green) are Ki67 positive (red) 3 and 14 days after MCAo. Scale bars represent 50 μm. b Orthogonal views of CX3CR1GFP/+ (green)
and Ki67+ (red) showing cellular co-localization. On the right, percentage of double-positive CX3CR1GFP/+/Ki67+ cells over the total CX3CR1GFP/+ cells in
the ischemic brain 3 and 14 days after MCAo (n = 4 mice/group). c Ki67+ cells do not co-localized with CCR2RFP/+ cells in the ischemic region 3 days
after MCAo
Fig. 2 Morphological diversity of CX3CR1GFP/+ and CCR2RFP/+ infiltrating Mo/MΦ. a CX3CR1GFP/+ cells (green) show three different phenotypes at
14 days after MCAo: amoeboid cells (upper left), ramified cells (upper right), and elongated cells located along the vessels (lower left). Blood vessels
were immunostained with the endothelial marker GLUT1 (red). Scale bars represent 15 μm. Graph bars represent the frequencies for each described
phenotype in the core (C) and periphery (peri-infarct; PI) of the lesion (n= 4 mice/group). b CCR2RFP/+ cells (red), which are localized in the core of the
ischemic lesion (a), have a round shape (arrowheads), while CX3CR1GFP/+CCR2RFP/+ double-positive cells (arrows), have an amoeboid or spindle shape
with lower level of RFP expression than CCR2RFP/+ cells (a and b). CX3CR1GFP/+ cells acquire a ramified phenotype as they localized in the periphery
(b and c). Scale bars represent 20 μm
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amoeboid macrophages, and as described above, their
distribution was limited to the ischemic core 14 days
after MCAo (Fig. 2b). Some CCR2RFP/+CX3CR1GFP/+
double-positive cells showed cellular processes (Fig. 2B),
suggesting that CCR2+ cells may acquire a CX3CR1
phenotype in the tissue.
To investigate whether proliferation of brain recruited
Mo/MΦ may also contribute to the increase in the num-
ber of accumulated Mo/MΦ over the time after stroke,
we performed immunohistochemistry with the proliferation
marker Ki67 (Fig. 3). Some CX3CR1GFP/+ macrophages on
the brain surface were positive for Ki67 (11.3 ± 2.1 % of
total CX3CR1GFP/+ cells) 3 days after MCAo (Fig. 3a) and
14 days after MCAo, Ki67 co-labeled with CX3CR1GFP/+
Mo/MΦ macrophages localized either in the parenchyma
or on the brain surface (Fig. 3a). However, at this time
point, the number of CX3CR1GFP/+Ki67+ Mo/MΦ
accounted for only 1.0 ± 0.3 % of total CX3CR1GFP/+ cells
(Fig. 3b). We did not observe CCR2RFP/+Ki67+ cells
(Fig. 3c). Ki67 staining in head-shielded mice also revealed
proliferation of CX3CR1GFP/+ Mo/MΦ (Additional file 1:
Figure S1C).
CX3CR1GFP/+ cells are phenotypically distinct from
endothelial cells, smooth muscle cells, pericytes,
oligodendrocytes, neurons, and astroglia
Next, we sought to determine if CX3CR1GFP/+ cells dif-
ferentiated into other cells types (Fig. 4). CX3CR1 is
expressed by BM-derived endothelial progenitor cells [27],
and BM-derived CX3CR1+ progenitors can contribute to
neointimal smooth muscle cell formation [28, 29]. In
addition, pericyte progenitors reside in the BM compart-
ment from where they are mobilized after stroke [30, 31].
Therefore, considering their vascular proximity, we
determined whether CX3CR1GFP/+ cells expressed
endothelial, pericyte or vascular smooth muscle cell
markers. However, GLUT1+ endothelial cells, PDGFRβ+
pericytes, and α-actin+ smooth muscle cells, while closely
associated with CX3CR1GFP/+ cells, did not express
GFP (Fig. 4a–c). In contrast, amoeboid, ramified, and
perivascular CX3CR1GFP/+ cells were all positive for the
microglia/MΦ marker Iba1 (Fig. 4d; Additional file 2:
Figure S2), indicating their myeloid origin. CX3CR1GFP/+
Mo/MΦ did not show expression of astrocytic (GFAP),
oligodendrocyte (Olig2), or neuronal (NeuN) markers
(Additional file 3: Figure S3).
Infiltration of CCR2+Ly6Chi and CCR2−Ly6Clo cells in
CCR2- or NR4A1-null mice after ischemic injury
To investigate whether the late surge of CX3CR1+
Mo/MΦ was due to active recruitment of circulating
CX3CR1+Ly6Clo monocytes or to transdifferentiation
of invading CCR2+Ly6Chi into CX3CR1+Ly6Clo Mo/MΦ,
we studied Mo/MΦ dynamics in CCR2−/− mice, in which
tissue recruitment of CCR2+Ly6Chi monocytes is impaired
[32] and in chimeric mice lacking NR4A1−/−, a transcrip-
tion factor required for the generation of CX3CR1+Ly6Clo
circulating monocytes [16]. These studies were conducted
by flow cytometry using Ly6C expression as a surrogate
marker for CCR2+ and CX3CR1+ Mo/MΦ identification.
Fig. 4 CX3CR1GFP/+ Mo/MΦ do not express vascular markers. CX3CR1GFP/+ cells do not express endothelial (GLUT1) (a), pericyte (PDGFRβ) (b), or
smooth muscle cells (α-actin) (c) markers 14 days after MCAo but are positive for the microglia/macrophage marker Iba1 (d). Scale bars represent
50 μm. c Disorganized blood vessel (arrowhead) shows spotty α-actin staining and surrounding CX3CR1GFP/+ cells (thin arrows), as compared with
an adjacent intact vessel (§), which shows uniform α-actin staining and no associated CX3CR1GFP/+ cells
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To validate this approach, we analyzed the blood of
CX3CR1GFP/+CCR2RFP/+ chimeric mice by flow cytometry.
This analysis identified that GFPhiRFPlo cells corresponded
to Ly6Clo monocytes (CD45+Ly6G−CD11b+Ly6Clo cells),
whereas GFPintRFPhi cells corresponded to Ly6Chi mono-
cytes (CD45+Ly6G−CD11b+Ly6Chi cells) (Additional file 4:
Figure S4). NK cells and some CD8 cells also expressed
RFP, as previously reported [25], but neutrophils did not
express either RFP or GFP.
In agreement with previous studies, flow cytometry of
blood from CCR2−/− mice showed reduced number of
Ly6Chi cells, because CCR2 is required for egression of
Ly6Chi monocytes from BM [33]. However, the number
of circulating Ly6Clo monocytes was not reduced
(Additional file 5: Figure S5). Since CCR2 is critical
for the recruitment of circulating monocytes to the brain
[8, 25, 34], we predicted that recruitment of Ly6Chi mono-
cytes would be reduced in CCR2−/− mice at 3 days after
MCAo, while Ly6Clo Mo/MΦ would be present at 14 days
only if the latter were recruited de novo from circulating
CX3CR1+Ly6Clo cells. In agreement with our findings in
CX3CR1GFP/+CCR2RFP/+ mice, WT mice showed consid-
erable infiltration of CD45hiCD11b+Ly6G−Ly6Chi Mo/MΦ
3 days after MCAo (26 ± 5 × 103 cell/hemisphere), while
CCR2−/− mice largely lacked infiltrating monocytes
(0.10 ± 0.08 × 103 cell/hemisphere) (Fig. 5a). Because
the infarct volume, evaluated 3 days after MCAo, was
slightly higher in CCR2−/− (57 ± 4 mm3) than in WT mice
(47 ± 2 mm3; p = 0.049, n = 6/group), the lack of monocyte
recruitment to the brain was unlikely to be due to a re-
duced post-ischemic inflammatory response in CCR2−/−
mice. Fourteen days after MCAo, there was a large increase
of Ly6Clo Mo/MΦ in WT mice (25 ± 12 × 103 cell/hemi-
sphere), while only few Ly6Clo Mo/MΦ were observed in
the brains of CCR2−/− mice (1.6 ± 0.3 × 103 cell/hemi-
sphere) (Fig. 5b). At this point, the tissue damage measured
by brain atrophy tended to be higher in CCR2−/− (13.2 ±
3.2 mm3) mice as compared to WT mice (7.7 ± 3.5 mm3,
p = 0.2, n = 5–6/group) (Additional file 5: Figure S5).
These results suggest that either Ly6Clo Mo/MΦ de-
rived from infiltrating CCR2+Ly6Chi monocytes or that
parenchymal CCR2+Ly6Chi Mo/MΦ are required for the
infiltration of CX3CR1+Ly6Clo monocytes to occur. To
address this issue, we studied Mo/MΦ kinetics in mice
deficient for the orphan nuclear receptor NR4A1
(Nur77). NR4A1 is essential for the generation of Ly6Clo
monocytes and NR4A1−/− mice lack circulating Ly6Clo
monocytes [16]. Since NR4A1 has been implicated in
neuronal function [35], we used NR4A1−/− chimeras
lacking NR4A1 in BM-derived cells to avoid confound-
ing effects of deletion of NR4A1 in neurons. As ex-
pected, Ly6Clo monocytes were absent in the blood of
Fig. 5 Ly6Chi and Ly6Clo Mo/MΦ do not accumulate in the brain of CCR2−/− mice after MCAo. a Flow cytometry analysis of infiltrating Mo/MΦ,
identified by high expression of CD45 and CD11b and low expression of Ly6G (CD45hiCD11b+Ly6G−), shows an increase of Ly6Chi Mo/MΦ as
compared with Ly6Clo Mo/MΦ in the wild type (WT) mouse 3 days after MCAo. The accumulation of both Ly6Chi and Ly6Clo Mo/MΦ is abolished
in CCR2−/− mice. b Brain-resident Ly6Clo Mo/MΦ outnumbered Ly6Chi Mo/MΦ in WT mice 14 days after MCAo, while neither Ly6Chi or Ly6Clo
Mo/MΦ increased in CCR2−/− mice (n = 4 mice/group). *p < 0.05 vs. WT
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NR4A1−/− BM chimeric mice, while circulating Ly6Chi
monocytes were comparable in number to those of mice
transplanted with WT BM (Fig. 6a). However, the num-
ber of brain Ly6Clo Mo/MΦ significantly increased in
NR4A1−/− BM chimeric mice 14 days after MCAo
compared to the number of Ly6Clo Mo/MΦ at 3 days
post-MCAo (Fig. 6b), consistent with the hypothesis
that infiltrating CCR2+Ly6Chi cells transdifferentiate
into CX3CR1+Ly6Clo Mo/MΦ at later times.
Discussion
We have demonstrated that two main subsets of blood-
derived macrophages accumulate in the post-ischemic
brain within distinct temporal and spatial patterns. While
CCR2+ Mo/MΦ spread through the ischemic lesion in the
absence of CX3CR1+ Mo/MΦ at the early phase (3–5 days
post-MCAo), the latter accumulated in the peri-infarct
zone, encircling the lesion filled of CCR2+ Mo/MΦ at the
late phase (14–28 days post-MCAo). Using mice lacking
either CCR2+Ly6Chi or CX3CR1+Ly6Clo monocytes, we
also provided evidence that CCR2+Ly6Chi Mo/MΦ
give rise to CX3CR1+Ly6Clo Mo/MΦ independently of
CX3CR1+ circulating monocytes. CX3CR1+Ly6Clo Mo/
MΦ can adopt three different myeloid phenotypes in the
ischemic brain depending on their localization: ramified
phenotype reminiscent of an intermediate state of acti-
vated microglia in the peri-infarct, amoeboid phenotype
consistent with phagocytic macrophages in the infarct re-
gion, and elongated perivascular macrophages associated
with blood vessels.
Blood-derived macrophages accumulate sequentially in
the ischemic brain
The number of both CX3CR1GFP/+ and CCR2RFP/+
Mo/MΦ on days 1 and 2 after ischemia was low and
similar to the number in brains of sham animals. These
data indicate that sizable infiltration of macrophages in the
brain does not occur before several days after the ischemic
event, as previously described [4, 36, 37]. While CCR2+
Mo/MΦ predominated during the first 3–5 days after
stroke, CX3CR1GFP/+ Mo/MΦ number strikingly increased
at 14 and 28 days. CCR2+ and CX3CR1+ Mo/MΦ accumu-
lated in the ischemic brain with a distinctive biphasic pro-
file. At day 3, we observed a drastic increase of CCR2+
Mo/MΦ, whereas CX3CR1+ Mo/MΦ only moderately in-
creased. Nearly all CCR2+ Mo/MΦ were located in the in-
farct area, consistent with an active involvement in the
inflammatory processes occurring in the territory most af-
fected by ischemia. In contrast, the CX3CR1+ Mo/MΦ
were mostly found at the infarct’s periphery, both rostrally
Fig. 6 Brain Ly6Clo Mo/MΦ develop independently of circulating Ly6Clo monocytes after MCAo. a Blood flow cytometry analysis shows absence
of Ly6Clo monocytes, identified by expression of CD115 and low Ly6G expression, in NR4A1−/− BM chimeric mice (n = 6 mice/group). *p < 0.05 vs.
irradiated WT mice (WT→WT). b Brain flow cytometry analysis from NR4A1−/− chimeric mice shows an increase of infiltrating Ly6Clo Mo/MΦ,
identified by high expression of CD45 and CD11b and low expression of Ly6G (CD45hiCD11b+Ly6G−), 14 days after MCAo compared to 3 days
after MCAo. *p < 0.05 vs. 3 days
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and caudally. By 7 days, CX3CR1+ Mo/MΦ outnumbered
CCR2+ Mo/MΦ in the infarct’s periphery and continued to
increase reaching a maximum at 14 days. At 28 days, num-
bers of CX3CR1+ Mo/MΦ were still elevated, suggesting
that Mo/MΦ participate in inflammatory processes also in
the chronic phase of the injury.
Our data define two distinct regions within the chronic
ischemic brain lesion: a cavitated core filled with CCR2+
and CX3CR1+ Mo/MΦ and a surrounding area of exten-
sive neuronal loss heavily populated by CX3CR1+ but not
CCR2+ Mo/MΦ.
Phenotypic differentiation of CX3CR1+ Mo/MΦ occurs
surrounding the ischemic lesion
While CCR2+ Mo/MΦ retained a round/amoeboid pheno-
type, commonly associated with phagocytic activity [38]
throughout the time period studied, CX3CR1+ Mo/MΦ
displayed three distinct phenotypes: amoeboid, ramified
and elongated perivascular. Like CCR2+ Mo/MΦ, amoeboid
CX3CR1+ Mo/MΦ were predominantly located in the
center of the lesion. Interestingly, we observed an in-
creased numbers of double-positive cells in this area,
possibly indicating that the conversion of CCR2+ into
CX3CR1+ Mo/MΦ occurs in the lesion center. The fact
that we did not observe CCR2+ Mo/MΦ with any other
morphology than amoeboid suggests that the morpho-
logical polarization of Mo/MΦ is linked to CCR2
down-regulation and concomitant up-regulation of CX3CR1.
Indeed, in human monocytes, CCR2 is down-regulated
as the monocytes differentiate into macrophages [39].
With the exception of the necrotic center, ramified
CX3CR1+ Mo/MΦ were evenly distributed throughout
the infarct without any apparent regional preference.
Due to their high Iba1 expression and cytoplasmic
arborization, these cells were essentially indistinguish-
able from activated microglia. Many of CX3CR1+ Mo/
MΦ with elongated cell bodies were associated with
cerebral blood vessels. These CX3CR1+ Mo/MΦ were
strictly located on the abluminal side of the vessel and
were also abluminal to pericytes and smooth muscle
cells lining the vessel. Interestingly, CX3CR1+ Mo/MΦ
did not cover all vessels uniformly but were associated
with blood vessel that showed disruption of integrity as
manifested by uneven or discontinuous smooth muscle
cell coverage (Fig. 4c). While we can only speculate on
their function, it is possible that vessel-associated
CX3CR1+ Mo/MΦ support vascular integrity by phys-
ically strengthening the wall of vessels damaged by
the ischemic injury. The recent findings that monocyte
depleted mice showed a higher rate of hemorrhagic
transformation after ischemic stroke support this view
[8]. On the other hand, vessel-associated Mo/MΦ
may participate in the removal of damaged vessels to
allow vascular replacement by angiogenesis. While
this possibility cannot be excluded, we did not see any
intracellular inclusions positive for vascular markers
(e.g. GLUT1, α-actin) that would indicate a phagocytic
activity of these cells.
Infiltration of inflammatory CCR2+Ly6Chi may give rise to
CX3CR1+Ly6Clo in the ischemic brain
Several perivascular CX3CR1+Ly6Clo Mo/MΦ were
immunopositive for Ki67 3 days after MCAo but only
few proliferative CX3CR1+Ly6Clo Mo/MΦ, exhibiting
mostly a ramified phenotype, were observed at later pe-
riods. Low rates of Mo/MΦ proliferation have also been
reported in a mouse model of permanent cerebral ische-
mia [19]. Considering these low proliferation rates, it is
more likely that the increased numbers of brain Mo/MΦ
are the result of continuous recruitment of hematogenous
monocytes than from cell proliferation in situ. Kokovay et
al. [40] also reported that recruited bone marrow-derived
cells into the brain expressing microglia markers were
only occasionally proliferative. Interestingly, this study de-
scribed a high number of Ki67+ cells associated with blood
vessels 3–14 days after ischemia and between 10 and 20 %
of the Ki67+ cells were identified as BM-derived pericytes.
Contrary to the Kokovay study, however, we found that
these perivascular cells expressed markers of the myeloid
lineage but not pericytes, a discrepancy possibly due to the
use of different pericyte markers (PDGFRβ in our study
vs. desmin).
On the other hand, the increase in CX3CR1GFP/
+CCR2RFP/+ double-positive cells in the ischemic lesion
before the rise of CX3CR1GFP/+ single positive cells
suggests that CX3CR1+Ly6Clo derive from infiltrating
CCR2+Ly6Chi Mo/MΦ and not from a hematogenous
source. This premise is supported by the observation
that mice deficient in CCR2 did not exhibit significant
numbers of both Ly6Chi and Ly6Clo Mo/MΦ in the is-
chemic brain, despite a normal number of circulating
Ly6Clo monocytes. Furthermore, in chimeric mice lacking
the transcription factor NR4A1 in BM-derived cells,
Ly6Clo monocytes were drastically reduced in the circula-
tion, but Ly6Clo Mo/MΦ were still observed in the brain
14 days after stroke. Therefore, the Ly6Clo Mo/MΦ
present in the post-ischemic brain could not have origi-
nated from circulating Ly6Clo monocytes. These observa-
tions raise the possibility that CX3CR1+Ly6Clo Mo/MΦ
differentiate from CCR2+Ly6Chi Mo/MΦ in situ, ra-
ther than originate from infiltrating CX3CR1+Ly6Clo
blood monocytes. Our data are consistent with the
observations by Gliem et al. [8] of reduced accumula-
tion of differentiated macrophages (identified as
Ly6cloF4/80hi) in CCR2−/− mice 6 days after ischemia.
Thus, CCR2+Ly6Chi Mo/MΦ could be precursors for
CX3CR1+Ly6Clo Mo/MΦ from which they develop
through environmental cues provided by the ischemic
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brain tissue, as has been recently suggested [19]. The
signals and their target receptors responsible for this
phenotypic shift remain to be determined.
Because CX3CR1+Ly6Clo Mo/MΦ have been linked to
post-ischemic repair in several organs including the
brain [8, 41–43], our findings have important implications
for therapies targeting the migration of inflammatory leu-
kocytes into the ischemic brain. Indeed, depletion of circu-
lating CCR2 monocytes impairs long-term spontaneous
behavioral recovery after stroke [37], while Ly6Clo mono-
cyte deficiency does not affect functional recovery and
severity of injury after hypoxia/ischemia in mice [18]. All
these findings suggest that inhibiting the recruitment of
presumably proinflammatory CCR2+Ly6Chi monocytes
would also prevent the development of potentially
protective CX3CR1+Ly6Clo Mo/MΦ, which might
affect repair processes during the subacute and chronic
phase of ischemic brain injury. Therefore, therapies
directed at interfering with monocyte recruitment into
the ischemic brain must take into account the stage of
evolution of the damage and the phenotype of the cells
involved.
Conclusions
In conclusion, we have investigated the time course and
phenotypic characteristics of monocytes recruitment into
the post-ischemic brain. We found that “inflammatory”
monocytes (CCR2+Ly6Chi) are recruited into the brain in
the acute phase of the damage resulting in early accumula-
tion of CCR2+Ly6Chi Mo/MΦ. A secondary accumulation
of CX3CR1+Ly6Clo Mo/MΦ ensues weeks later, which is
most likely the result of a phenotypic switch of CCR2
+Ly6Chi Mo/MΦ rather than recruitment of blood borne
“patrolling” monocytes (CX3CR1+Ly6Clo). The morpho-
logical diversity of CCR2+Ly6Chi and CX3CR1+Ly6Clo
Mo/MΦ suggests a diversity of roles in the development
and resolution of the damage. Although the molecular
cues driving the phenotypic switch and its impact on
tissue outcome remain to be defined, the data provide
new insight into the complexities of monocyte trafficking
into the brain with significant implications for
immune-based approaches to ameliorate ischemic brain
injury by modulating the cellular bases of post-ischemic
inflammation.
Additional files
Additional file 1: Figure S1. CX3CR1GFP/+ and CCR2RFP/+ infiltrating
monocytes after stroke in head-shielded CCR2RFP/+CX3CR1GFP/+ chimeric
mice. (A) Coronal brain section images of BM CCR2RFP/+CX3CR1GFP/+
chimeric mice 3 and 14 days after MCAo showing anatomical localization
of accumulated CCR2RFP/+ (red) and CX3CR1GFP/+ (green) cells in the
ischemic hemisphere. (B) Cell number quantification of infiltrating
CX3CR1GFP/+ and CCR2RFP/+ in the ischemic hemisphere 3 and 14 days
after MCAo. (C) Representative images and orthogonal views of co-staining
of CX3CR1GFP/+ Mo/MΦ (green) with the proliferation marker Ki67 (red)
showing CX3CR1GFP/+ Mo/MΦ 14 days after MCAo. (D) CX3CR1GFP/+ cells
(green) show three different phenotypes: cells with an amoeboid shape
(left), perivascular cells with elongated shape located along the vessels
(center panels; transverse and longitudinal vessel cross sections, respectively)
and cells with ramified processes (right) 14 days after MCAo. Blood vessels
were immunostained with the endothelial marker GLUT1 (red). (PDF 4803 kb)
Additional file 2: Figure S2. CX3CR1GFP/+ Mo/MΦ do not differentiate
into neurons, astrocytes, or oligodendrocytes. Staining for NeuN (A),
GFAP (B), and Olig2 (C) shows that infiltrating CX3CR1GFP/+ cells in the
peri-infarct or core of the ischemic hemisphere do not co-localize with
neuronal, astrocytic, or oligodendrocyte markers 14 days after MCAo,
respectively. Additionally, while CX3CR1GFP/+ cells, oligodendrocytes, and
astrocytes vastly populate the ischemic core neurons were only present
in the peri-infarct (A–C, right below panels). Scale bars represent 50 μm.
(PDF 3837 kb)
Additional file 3: Figure S3. Infiltrating CX3CR1GFP/+ and CCR2RFP/+
cells are monocyte/macrophages. (A) Representative fluorescent merged
images and orthogonal views of CX3CR1GFP/+ (green) and Iba1+ (red)
ramified (upper panels) and amoeboid cells (lower panels) showing
co-localization of both markers. The images were taken from the
ischemic hemisphere at 14 days post-MCAo. Scale bar represent
20 μm. (B) Representative fluorescent merged images and orthogonal
views of co-localization for the markers CCR2GFP/+ (red) and Iba1+
(blue). The images were taken from the ischemic hemisphere at 3 days
post-MCAo. Scale bar represent 20 μm. (PDF 10117 kb)
Additional file 4: Figure S4. CX3CR1GFP/+ and CCR2RFP/+ monocytes
overlap with Ly6Clo and Ly6Chi monocytes, respectively. Flow chart
showing sequential gating to identify leukocyte subsets expressing GFP
and/or RFP in the blood of CCR2RFP/+CX3CR1GFP/+ chimeric mice. While
Ly6Ghi neutrophils were GFP/RFP negative, we identified three different
subpopulations in CD45+ cells that showed green or/and red fluorescence:
a subset of cells expressing high level of GFP and low level of RFP
(GFPhiRFPlo, 1), a subset of cells expressing intermediate level of GFP and
high level of RFP (GFPintRFPhi, 2), and a subset of cells that only express RFP
(GFPloRFPhi, 3). GFPhiRFPlo and GFPintRFPhi subsets were identified as Ly6Clo
and Ly6Chi monocytes (CD45hiCD11b+Ly6G−), respectively. Additionally, a
subset of GFPloRFPhi cells were identified mainly as NK cells and to a lesser
extent as CD8+ cells. (PDF 791 kb)
Additional file 5: Figure S5. Monocyte blood analysis and brain injury
quantification in CCR2−/− mice after MCAo. (A) Blood flow cytometry
analysis showed decreased numbers of Ly6Chi monocytes, but not of
Ly6Clo monocytes, in CCR2−/− mice as compared to WT mice (n = 5
mice/group). *p < 0.05 vs. WT mice. (B) Ischemic lesion and brain atrophy
were evaluated using T2-weighted MRI in WT and CCR2−/− mice. Injury
volume was evaluated by measuring hyperintense areas on T2 at 3 days
post-MCAo (red outline), and brain atrophy was evaluated on T2 images
by subtracting the volume of intact tissue in the ipsilateral hemisphere
(red outline) from that in the contralateral hemisphere (blue outline) [44]
at 14 days post-MCAo. (PDF 1172 kb)
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